{"nct_id":"NCT00051103","title":"Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.","status":"COMPLETED","status_verified_date":"2015-04","start_date":"2002-10","start_date_type":null,"primary_completion_date":"2005-06","primary_completion_date_type":"ACTUAL","completion_date":"2005-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}